Hashimoto Yosuke, Shimizu Taro, Abu Lila Amr Selim, Ishida Tatsuhiro, Kiwada Hiroshi
Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima.
Biol Pharm Bull. 2015;38(3):417-24. doi: 10.1248/bpb.b14-00653.
PEGylation, which is the surface modification of nanocarriers with polyethylene glycol (PEG), has increased the circulation time and reduced the immunogenic responses to nanocarriers. However, many reports have demonstrated that the intravenous injection of sterically stabilized PEGylated liposome (SL) causes an accelerated blood clearance (ABC) of subsequent doses via anti-PEG immunoglobulin M (IgM)-mediated complement activation. In the present study, the relationships between serum anti-PEG IgM concentration, the intensity of complement activation and the hepatic clearance of SL were quantitatively investigated for their role in the ABC phenomenon. Interestingly, with increasing serum anti-PEG IgM concentrations, the intensity of complement activation increased linearly, while the intensity of the hepatic clearance of SL was increased and then saturated. In addition, only 15-17% of anti-PEG IgM in blood circulation induced by SL at different doses was associated with a second dose SL. The present results indicate that it is the hepatic uptake of SL that is the limiting step in the ABC phenomenon, rather than the association of anti-PEG IgM to the SL and a subsequent complement activation.
聚乙二醇化,即将纳米载体用聚乙二醇(PEG)进行表面修饰,增加了纳米载体在体内的循环时间并降低了其免疫原性反应。然而,许多报告表明,静脉注射空间稳定的聚乙二醇化脂质体(SL)会通过抗PEG免疫球蛋白M(IgM)介导的补体激活导致后续剂量的加速血液清除(ABC)。在本研究中,定量研究了血清抗PEG IgM浓度、补体激活强度与SL肝脏清除率之间的关系,以探讨它们在ABC现象中的作用。有趣的是,随着血清抗PEG IgM浓度的增加,补体激活强度呈线性增加,而SL肝脏清除强度则先增加后饱和。此外,不同剂量的SL在血液循环中诱导产生的抗PEG IgM只有15% - 17%与第二剂量SL相关联。目前的结果表明,在ABC现象中,SL的肝脏摄取是限制步骤,而非抗PEG IgM与SL的结合以及随后的补体激活。